Science
Design Therapeutics Inc (NASDAQ:DSGN) Adds 11.61 Percent In A Week: What Motivates The Stock?
In last trading session, Design Therapeutics Inc (NASDAQ:DSGN) saw 0.58 million shares changing hands with its beta currently measuring 1.84. Company’s recent per share price
